About the Role
You are the first dedicated seller for our site business, responsible for winning clinical research sites from initial contact through to a signed pilot and becoming a paying customer. You will build and execute the go-to-market strategy.
Responsibilities
- Self-source pipeline through outbound efforts, content creation, in-person site visits, and managing the conference calendar.
- Manage the full sales cycle from discovery to pilot setup and conversion to paid accounts.
- Build the sales playbook, including initial sequences and collateral, and provide feedback to the product team based on market insights.
- Launch and move sourced pilots toward conversion.
- Ship a first version of the outbound playbook and initial tailored collateral within the first 90 days.
- Work directly with the founding team on deals, pricing, and strategy.
Requirements
- 2 to 10 years of B2B sales experience, with a strong trajectory.
- A background in a startup, ideally in a sales role.
- Proven ability to self-source leads relentlessly and close loops independently.
- Experience using AI for sales campaigns and messaging.
- Ability to produce clean, accurate, and tailored written outreach.
- Curiosity about the market and product, including tracking competitors.
- Willingness to build the sales machine rather than operate an existing one.
- Comfort with ambiguity and a desire to own a revenue motion.
- Willingness to accept founding-level equity and associated risk.
Skills
- B2B Sales
- Go-to-Market Strategy
- Pipeline Generation
- Outbound Sales
- Content Creation
- Conference Management
- Sales Playbook Development
- Collateral Creation
- Product Feedback
- AI for Sales
- Written Communication
- Market Research
- Competitive Analysis
Location
- San Francisco
Work Type
- Full-time
- Hybrid (3 days/week in office)
Experience Level
- Founding Level
- Mid-Level
- Senior Level
Salary/Compensations
- $200k OTE (On-Target Earnings)
Benefits
- Medical
- Dental
- Vision
- 401k
- Company computer
- Office events
- Founding-level equity
About the Company
- Double Blind Bio builds AI agents to reduce the operational load on clinical trials, allowing research teams to focus on patients and science.
- We sell to research sites (monthly subscription for growth module) and pharma sponsors (per trial for engagement module).
- We have over 300 research sites live on our platform.
- Backed by Define Ventures, SignalFire, and Peterson Ventures.
- The team comprises individuals from leading tech and life science companies.
